Bactine
This article was originally published in The Tan Sheet
Executive Summary
Bayer's topical antiseptics line repositioned as "soothing infection protection." Revamped brand has been modernized, but retains recognizable green cap, red circle on packaging. Pain Relieving Cleansing Spray, Wipes and Protective Antibiotic ointment, which retail for $6.60, $4.74, $4.50, respectively, join Original First Aid Liquid. Wipes are "individually wrapped for convenient first aid anywhere, any time," Bayer says. New products reached shelves in March and are being supported by an ad campaign running through the fall. Ads airing on network, cable TV and running in parenting, women's magazines claim "New Bactine takes the pain out of killing germs." Agency is BBDO New York...
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.